Y0002081

Moxifloxacin for peak identification B

European Pharmacopoeia (EP) Reference Standard

• Sinônimo(s): Moxifloxacin, 1-Cyclopropyl-6-fluoro-8-methoxy-7-[(4aS,7aS)-octahydropyrrolo[3,4-b]pyridin-6-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
• Fórmula empírica (Notação de Hill): C₂₁H₂₄FN₃O₄
• Número CAS: 151096-09-2
• Peso molecular: 401.43
• Código UNSPSC: 41116107
• NACRES: NA.24

Propriedades

• grau: pharmaceutical primary standard
• família API: moxifloxacin
• fabricante/nome comercial: EDQM
• formato: neat
• temperatura de armazenamento: 2-8°C
• InChI: 1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1
• chave InChI: FABPRXSRWADJSP-MEDUHNTESA-N

Descrição

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Moxifloxacin for peak identification B EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Embalagem

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Outras notas

Sales restrictions may apply.

Informações de segurança

• Pictogramas: GHS07,GHS09
• Palavra indicadora: Warning
• Frases de perigo: H302,H319,H411
• Declarações de precaução: P273 - P301 + P312 + P330 - P305 + P351 + P338
• Classificações de perigo: Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Irrit. 2
• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 2
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable